Vatring Pharmaceuticals Inc Bluefield, VA - 24605

Vatring Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Bluefield, VA and active since 1999.

Vatring Pharmaceuticals Inc was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Mark Hounshell at the company’s single location by writing to 1121 Virginia Avenue, Bluefield, Virginia VA 24605 or by phoning (276) 322-1888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vatring Pharmaceuticals Inc
Contact Person: Mark Hounshell
Address: 1121 Virginia Avenue, Bluefield, Virginia 24605
Phone Number: (276) 322-1888
Annual Revenue (USD): $500.000 to $999.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Vatring Pharmaceuticals Inc was started in 1999 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mark Hounshell for inquiries that concern Vatring Pharmaceuticals Inc by calling the company number (276) 322-1888, as your correspondence is most welcome. Additionally, the physical location of the single location of Vatring Pharmaceuticals Inc can be found at the coordinates as well as the street address 1121 Virginia Avenue in Bluefield, Virginia 24605.

For its online presence, you may visit Vatring Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.